Does Meta's new stock class change your RSU offer?

What did Meta actually announce, and does it touch your RSUs?

Meta's new stock class doesn't cut the value of RSUs you already hold, and it doesn't shrink an offer sitting on your desk. On 21 October 2026, alongside third-quarter results, Meta's board created a publicly listed, non-voting Class C common stock and declared a one-time dividend of one Class C share for every Class A and Class B share outstanding, effective 19 January 2027. Functionally, that behaves like a two-for-one split. Meta's own filings confirm the board approved an equitable adjustment to every award outstanding under the 2012 and 2025 equity plans, so each Class A share underlying your grant now carries one Class C share alongside it.

Run the arithmetic and almost nothing moves. If you hold 400 unvested units against a share price near $700, you come out with 800 units tracking a price near $350. Your slice of the company is identical, your vest dates don't shift, and the dollar value of the unvested balance is unchanged on day one. The share pool under the 2025 plan was adjusted the same way, without being enlarged. What genuinely changes is what Meta is permitted to hand out next: a plan amendment lets the company settle future awards in either Class A or Class C shares, at its own discretion, without increasing the aggregate pool.

The reason sits in the cash flow statement. Meta narrowed 2026 capital expenditure guidance to $135–145 billion and lifted total expenses to $175–179 billion. Third-quarter capex of $34.91 billion outran $32.79 billion of operating cash flow, pushing free cash flow to negative $2.12 billion. Long-term debt climbed $22.2 billion over nine months to $80.9 billion, and the company ran no buybacks in 2026 after $26.2 billion in the first nine months of 2025. A tradeable non-voting class gives Meta another funding tap — share sales — without touching control. No shareholder vote was required: entities tied to Mark Zuckerberg and Priscilla Chan, holding 56.1% of voting power, approved it by written consent.

Which share class are my RSUs actually granted in?

Right now they're Class A. From 19 January 2027, they could be either class — and that's the single line worth pinning down in writing. Meta's amended 2025 Equity Incentive Plan permits awards to be settled in Class A or non-voting Class C shares, so a grant letter signed in November for a February start may well settle in a class that didn't exist when you negotiated. Ask recruiting one plain question: which class of common stock will my RSUs settle in, and is that specified in the grant agreement? If the answer is "we're still finalising that," you've learned something useful — the letter's language is boilerplate and you should read it closely.

There's a decade of precedent for how this plays out. Alphabet created its non-voting Class C shares in 2014 through the same two-for-one mechanism, and most new employee grants have been denominated in that class since 2023. Economic rights are identical across Alphabet's classes, and the two listed tickers typically trade within about a percentage point of each other, with the spread flipping direction depending on market conditions rather than settling into a permanent discount. Voting power isn't what public markets price; cash flows are. So the class your units settle in is rarely where the money is won or lost in a tech offer.

The conversion price is where it's won or lost. Meta sizes RSU grants in dollars, then converts that figure into a share count using an average closing price around the grant date — commonly the average over the month before your start. A two-for-one recapitalisation lands mid-cycle, which means the ticker used and the averaging window chosen directly set how many units you receive. Get the method in writing: which price series, which window, and which date the conversion is struck on. A $600,000 grant converted off a pre-split average versus a post-split average is the same dollar value only if someone applies the adjustment correctly.

What should I ask recruiting in writing before I sign?

Put five questions in writing before you sign: which share class the grant settles in, the gross dollar value of the award, the exact method for converting dollars into a share count, the vesting schedule with its first vest date, and the refresh policy from year two onwards. Email beats a phone call every time — a recruiter's cheerful "it's around 400 shares" is not a number anyone can be held to later. Keep the tone friendly and administrative: you're confirming details for your own financial planning, not auditing the company. Most recruiters answer all five without hesitating, because every answer already lives in the plan documents they're working from.

Vesting deserves its own paragraph in that email. Meta's standard pattern is 25% a year delivered quarterly — roughly 6.25% per tranche, no cliff — with vests landing on fixed calendar dates: 15 February, 15 May, 15 August and 15 November. Insider filings also show grants vesting in twentieths, so five-year, 20%-a-year variants exist in the wild. Confirm which one applies to your letter instead of trusting forum consensus. Ask which quarterly date your first tranche hits, too, because a start date that misses a cut-off by a fortnight can push your first vest three months out and reshape your cash flow for the whole first year.

Then ask the two things nobody volunteers. First: does the grant agreement allow Meta to substitute one class of common stock for another after the grant date? Second: what does refresh actually look like — discretionary, performance-rated, or formula-driven? Annual refreshers are what stop total compensation falling off a shelf in year four as the initial grant rolls off, and they're sized by rating, not by promise. You won't get a guarantee, and you shouldn't ask for one. You will learn whether refresh is a structural part of the model or a hopeful line in the recruiting pitch. Save the replies, dated, in a folder you can find in three years.

Do voting rights and dilution change what the grant is worth?

Voting rights are worth essentially nothing to you as an employee; dilution is the part that reaches your money. A non-voting class exists precisely so a company can sell stock to fund capital spending without the founder's control being diluted, and Meta described the Class C shares as usable for capital raising, employee compensation and acquisitions while preserving the voting power of existing Class A and Class B holders. Economic rights are identical across all three classes. If Meta issues a large tranche of Class C to pay for data centres, every shareholder absorbs the economic dilution — you included — and nobody absorbs control dilution. That asymmetry is the fair criticism of the structure.

Scale it and the numbers get concrete. At a market capitalisation near $1.78 trillion, each 1% of the company issued raises roughly $17.8 billion, which is real money against a $135–145 billion capex plan for 2026 alone. Here's my contrarian read: for an employee, that trade is defensible. Equity-funded infrastructure is sturdier than debt-funded infrastructure, and your units are worth more inside a company that can still write cheques without covenants pressing on it. Just be honest about what you're holding. A Meta RSU in 2027 is a geared bet on AI capital expenditure earning back its cost of capital, not a quiet index fund with a logo attached.

One detail reads as a genuine signal. Under a founder alignment agreement, Zuckerberg can freely sell only 20% of the Class C shares he receives; the remaining 80% are stapled, generally requiring him to sell or convert voting stock alongside them. That's a constraint rather than a loophole, and it's more alignment than most equity-heavy packages bother to offer. It also beats the alternative many senior candidates are weighing right now: private company paper with no market under it at all. If you're holding a Meta offer against a startup grant, the liquidity gap matters far more than the share class, and whether startup equity pays out at all in an acquisition is the prior question to settle.

How do I negotiate cash versus equity when the equity story gets messy?

Pull the levers in order of how movable they are: base salary first, then a sign-on bonus, then grant size, then vesting terms. Base is the hardest to shift and the most valuable, because it compounds into every raise, bonus and future offer you'll ever negotiate from. The line that lands is specific and unemotional: "I'm genuinely excited about the role. Given that the equity structure changes in January and I can't model the grant with any confidence yet, I'd like to see more of the package in base — could we get to $X?" Name the number. Vague asks collect vague answers and burn a round of goodwill.

If base is capped by the band, move straight to the sign-on and say so plainly: "Understood that base is at the top of the band. Can we bridge it with a sign-on that covers the unvested equity I'm leaving behind? That's $Y." Attach the figure from your current grant statement, because one-off cash is the easiest line in any package to get approved. Your third ask should be certainty rather than size — request that the grant letter state a share count outright, or spell out the conversion method and averaging window. Pricing an equity-heavy offer when the payout keeps sliding works through the same trade in more depth.

What doesn't work: treating the new share class as a grievance, or demanding Class A because it "has votes." Both read as someone who hasn't read the filings, and you lose credibility you'll need later in the conversation. Real leverage comes from somewhere else entirely — a second live offer, which is a volume game that happens well upstream of any negotiation. If applications aren't converting into first calls, the bottleneck usually isn't your experience; it's a CV an automated screen can't parse cleanly. A free CV check scores yours out of 100, breaks it into five categories including ATS compatibility, and shows a visual layout analysis before a recruiter ever opens the file.

Frequently asked questions